Surgeons were stunned when a routine brain biopsy revealed a living, 80mm predator thriving inside a patient’s frontal lobe.

A phase 2 trial showed that combining targeted radiotherapy with PD-1 blockade and a bevacizumab biosimilar can elicit responses in advanced liver cancer.

A red, parasitic worm turned out to be behind the woman's wide array of symptoms. | Credit: Hossain, M., Kennedy, K. J., ...

Vir Biotechnology, Inc. ( VIR) Q4 2025 Earnings Call February 23, 2026 5:30 PM EST ...

Despite a decided shortage of placebo-controlled trials in humans to support that advice, the business of longevity is ...

For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and ...

A research team at the University of Missouri has treated the first cancer patient with a new nuclear medicine device that targets tumors inside the liver. The early-stage clinical trial focuses on ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic ...

Hepatic cysts are quite common in the daily practice of radiologists and are generally described as simple cysts or as cystic lesions sparsely distributed throughout the parenchyma, often without the ...

Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...

Hi, I’m testing the MedSAM2_MRI_LiverLesion.pt checkpoint and I noticed it segments the entire liver organ instead of individual lesions. Lesions just show up as dark areas inside the liver mask. I ...